CTOR vs INTC · $105.2M cap vs rev $52.85B
Citius Oncology, Inc. (CTOR) versus Intel Corporation (INTC) — a side-by-side from cached financials, not a winner call.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
Intel Corporation (INTC) is a semiconductors company listed on US. It is led by Pat Gelsinger.
CTOR does not have a complete income-statement cache yet.
Latest reported INTC revenue for 2025-12-27 was $52.85B. Net income was -$267.0M. Revenue was down 0.5% from 2024-12-28 to 2025-12-27. INTC currently screens at market cap $498.43B.
CTOR currently screens at market cap $105.2M. INTC currently screens at market cap $498.43B.
Not investment advice. Open the CTOR and INTC stock pages for the full models.
Not investment advice.